Avoro Capital Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Avoro Capital Advisors LLC

  • $6.65 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$177.01 - $223.45 $118 Million - $148 Million
-664,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$181.39 - $202.99 $22.9 Million - $25.6 Million
-126,000 Reduced 15.95%
664,000 $120 Million
Q2 2021

Aug 16, 2021
SELL
$187.49 - $221.1 $114 Million - $135 Million
-610,000 Reduced 43.57%
790,000 $159 Million
Q1 2021

May 17, 2021
BUY
$207.02 - $241.31 $290 Million - $338 Million
1,400,000 New
1,400,000 $301 Million

Others Institutions Holding VRTX

# of Institutions
1,726
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email